GSK4716通过海马区HT22细胞中的葡萄糖皮质体受体信号传递来增强5-HT1AR表达

Juhee Lim1, Jiyeon Park1, Wonwoong Lee1

  • 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Woosuk University, Wanju-gun, Jeollabuk-do, Republic of Korea.

Neurological research
|March 31, 2024
PubMed
概括

GSK4716,一种与雌激素相关的受体玛激动剂,通过抑制抑制剂来增加血清素受体1A (5-HT1AR) 表达. 这一发现为小分子提供了调节5-HT1AR在血清神经传递中的潜力.